Surging global investments in oncology, rare genetic diseases, and novel biopharmaceutical modalities, alongside continuous regulatory framework refinements, are driving rapid growth across the global Breakthrough Therapy BT Designation Market. Breakthrough Therapy (BT) designation advisory, regulatory consulting, and accelerated clinical development services are essential for helping...

The integration of artificial intelligence for predictive trial recruitment, fully siteless trial architectures, and synthetic control arms derived from real-world data defines the future scope of the Decentralized Clinical Trials Market. Future clinical development frameworks aim to accelerate trial execution timelines through automated end-to-end digital workflows. In addition, AI matching...

NEWARK, Del., August 18, 2026 — The global Fisetin Market is valued at USD 308.5 million in 2026 and is projected to reach USD 757.6 million by 2036, expanding at a CAGR of 9.4% between 2026 and 2036, according to Future Market Insights (FMI). Growth is being supported by recurring capsule and powder production, rising demand for standardized flavonoid ingredients, and continued...

NEWARK, Del., August 5, 2026 — The global Fisetin Market is projected to expand as supplement manufacturers increasingly incorporate flavonoid ingredients into recurring capsule and powder formulations. According to Future Market Insights (FMI), the market is expected to grow from USD 308.5 million in 2026 to USD 757.6 million by 2036, registering a 9.4% CAGR during the forecast period....

NEWARK, Del. — According to Future Market Insights (FMI), the global hairy cell leukemia treatment market is valued at USD 412.8 million in 2026 and is projected to reach USD 753.3 million by 2036, expanding at a 6.2% CAGR during the 2026–2036 forecast period. Established treatment guidelines and defined intervention criteria continue to support demand for therapies among patients...

"Global Demand Outlook for Executive Summary Non-Small Cell Lung Cancer Diagnostics Market Size and Share CAGR Value The global non-small cell lung cancer diagnostics market is expected to reach USD 3,463.37 million by 2028 from USD 1,291.66 million in 2020, growing at a stead Global Non-Small Cell Lung Cancer Diagnostics Market report is a highly visual business report where the key...

"Regional Overview of Executive Summary Urothelial Carcinoma Treatment Market by Size and Share CAGR Value The expected CAGR of global urothelial carcinoma treatment market is tend to be around 20% in the mentioned forecast period. The market was valued at USD 0.81 billion in 2022, and it would grow upto USD 3.48 billion by 2030 The market report also contains the drivers and...

NEWARK, Del., Aug. 21, 2026 — The global Hypothalamic Obesity Market is expanding as healthcare providers increasingly recognize the need for disease-specific treatment approaches for patients experiencing persistent weight gain following hypothalamic injury. According to Future Market Insights (FMI), the market is projected to grow from USD 1.1 billion in...

The integration of artificial intelligence patient-matching algorithms, longitudinal multi-omic biomarker tracking, and blockchain-secured patient data registries defines the future scope of the Rare Disease Clinical Trials Market. Identifying undiagnosed rare disease patients hidden within general healthcare databases represents a major frontier in clinical research. In addition, AI natural...

Surging global demand for novel orphan drug therapies, expanding regulatory incentives for rare genetic disorder research, and continuous clinical trial innovations in decentralized patient recruitment are driving rapid growth across the global Rare Disease Clinical Trials Market. Rare disease clinical trials—comprising adaptive trial designs, decentralized clinical trial (DCT) platforms,...